Stratified management of residual gastric cancer risk after Helicobacter pylori eradication
Frontiers in Microbiology · 13.02.2026 · 17
DOI: 10.3389/fmicb.2026.1779490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 13.02.2026. Verfasst von Li Song und 1 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory and Department of Oncology, Tumor Hospital Affiliated to Nantong University, Nantong, Jiangsu, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Nantong Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Despite the established efficacy of Helicobacter pylori eradication in reducing gastric cancer (GC) incidence, a significant residual risk persists in successfully treated individuals, driven by lasting pathological alterations termed “oncogenic memory,” including irreversible mucosal damage (e.g., intestinal metaplasia), residual pro-inflammatory and epigenetic “molecular scars,” and gastric microbiome dysbiosis. This perspective synthesizes current evidence to advocate for a paradigm shift from a singular focus on pathogen clearance towards a comprehensive, risk-adapted management strategy. We propose a novel, dual-dimensional framework centered on a multidimensional risk assessment that integrates OLGA/OLGIM staging, demographic, lifestyle, and genetic factors to stratify post-eradication individuals into distinct risk categories. The framework subsequently outlines tailored surveillance protocols—specifying endoscopy frequency and advanced biomarker application—leverages technological support from AI-assisted endoscopy and molecular testing, and details differentiated resource allocation models based on regional GC incidence and economic development. This integrated approach provides a practical roadmap for implementing precision prevention, aiming to mitigate the lingering GC risk and ultimately reduce the global disease burden through a dynamic, lifelong management system beyond eradication. To facilitate implementation, we provide a user-ready risk calculator that operationalizes the multidimensional score for cohort-level application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Central Laboratory and Department of Oncology, Tumor Hospital Affiliated to Nantong University, Nantong, Jiangsu, China.
- School of Biological Science and Engineering, Southeast University, Nanjing, Jiangsu, China.
Förderung
- Natural Science Foundation of Nantong Municipal Science and Technology Bureau
Zitieren
APA
Song, L., & Yu, Q. Y. (2026). Stratified management of residual gastric cancer risk after Helicobacter pylori eradication. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1779490
Vancouver
Song L, Yu QY. Stratified management of residual gastric cancer risk after Helicobacter pylori eradication. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1779490
BibTeX
@article{Song2026,
author = {Song, Li and Yu, Qi-Ying},
title = {Stratified management of residual gastric cancer risk after Helicobacter pylori eradication},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1779490}
}
EUVIMED